Manufacturer record

SPM Drugs (P) Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by SPM Drugs (P) Ltd (Tamil Nadu) were declared Not of Standard Quality between January 2022 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to SPM Drugs (P) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2022 to May 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2022
2
Products affected
Description
Most common failure
May 2025
Latest alert

Flagged batches per year

2022 · 12025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Phenytoin Sodium Injection USP-2ml 45PSA138Mfg 2024-05 · Exp 2026-04 Sample does not conform to the requirement for assayAssay King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab May 2025
Adrenochrome Monosemicarbazone Injection, 2 ml 01ACA295Mfg 2021-02 · Exp 2022-07 Description & Particulate MatterDescription CDL KolkataCDSCO lab Jan 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.